Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
07/2009
07/23/2009US20090186351 Nucleotide analogs
07/23/2009CA2711384A1 Novel cytostatic 7-deazapurine nucleosides
07/22/2009EP2080525A1 Remodeling and Glycoconjugation of Peptides
07/22/2009EP2079313A2 Antimicrobial and antiviral compounds and methods for their use
07/22/2009EP2006293A9 2'-hydroxyl-modified ribonucleoside derivative
07/22/2009EP1973925A4 Dna chip for diagnosis of corneal dystrophy
07/22/2009EP1879906A4 Reversible nucleotide terminators and uses thereof
07/22/2009CN101490075A Substituted aryl piperidinylalkynyladenosines as A2AR agonists
07/22/2009CN101490074A 5'-modified bicyclic nucleic acid analogs
07/22/2009CN101486746A Avermectins substituted in the 4'-position having pesticidal properties
07/21/2009US7563887 Binds to different natural nucleobases and therefore display a degree of ambiguity, or universality, in their binding pattern; for detecting polymorphisms
07/21/2009US7563886 A system capable of releasing a specific molecule by external stimulation such as oxidation and photoirradiation without impairing a target nucleic acid; useful in gene analysis and for therapy and diagnosis of various diseases
07/16/2009WO2009086687A1 The synthesis method of decitabine
07/16/2009US20090181921 2-5a analogs and their methods of use
07/15/2009EP1794172B1 Antiviral 4'-azido-nucleosides
07/15/2009EP1144429B1 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
07/15/2009CN101481399A Method for synthesizing positive electron radioactive imaging agent labeled precursor thymidine derivative
07/15/2009CN100512879C Conjugate having cleavable linkage for use in liposome
07/14/2009US7560544 Immunomodulators; hepatitis C virus; 5-amino-3-(O-D-ribofuranosylthiazolo[4,5-d]pyrimidine-2,7(3H,6H) dione (7-thia-8-oxoguanosine)
07/14/2009US7560442 For prophylaxis and therapy of diabetes mellitus Type I and Type II, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases (Alzheimer's disease, Parkinson's disease), neuropathic diseases, neuropathic pain and polyneuropathy
07/14/2009US7560435 Therapeutic use of riboside of 5-aminoimidazole-4-carboxamide (acadesine)
07/09/2009WO2009086192A1 Biodegradable phosphate protected nucleotide derivatives and their use as cancer, anti viral and anti parasitic agents
07/09/2009WO2009085909A1 Crystal forms of 2-[2-(4-chlorophenyl)ethoxy]adenosine
07/09/2009WO2009082846A1 A capecitabine hydroxyl-derivative, its preparation processes and uses for preparing capecitabine
07/09/2009WO2009082844A1 A capecitabine hydroxyl-derivative, its preparation processes and uses for preparing capecitabine
07/09/2009US20090176968 Preparation of Triazole Containing Metal Chelating Agents
07/09/2009US20090176732 Protected nucleotide analogs
07/09/2009US20090176730 N4-acylcytosine nucleosides for treatment of viral infections
07/09/2009US20090176279 Bioreactive agents
07/09/2009US20090175914 Salts or Complexes of Methyl Donors With Phytic Acid or Its Derivatives and Method for the Synthesis Thereof
07/08/2009EP2077268A1 Process for preparing inhibitors of nucleoside metabolism
07/08/2009EP1904511B1 Homogemcitabines
07/08/2009CN101479290A Novel 2',3'-methylidene acetyl adenosine prodrugs for use as prodrugs for adenosine receptor agonists
07/08/2009CN101479289A Adenosine derivatives for the treatment of pain
07/08/2009CN101475621A Method for purifying clofarabine by using chromatographic column
07/08/2009CN101475620A Efficient energy-saving extraction and production method for high-purity cordycepin
07/07/2009US7556967 Foldable polymers as probes
07/07/2009US7556923 Conjugates between a minor groove binding the trimer of 1,2-dihydro- (3H)-pyrrolo(3,3-e)indole-7-carboxylate and an oligonucleotide and forms stable hybrids with complementary target sequence
07/07/2009CA2450033C Viral polymerase inhibitors
07/02/2009WO2009082720A2 Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9h-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as a2ar agonists
07/02/2009WO2009081833A1 Dried microorganism cell or microorganism extract containing stabilized (ss)-s-adenosyl-l-methionine, and method for production of the dried microorganism cell or microorganism extract
07/02/2009US20090171078 Method of sequencing nucleic acids using elaborated nucleotide phosphorotiolate compounds
07/02/2009US20090170805 Anti-microbial agents and uses thereof
07/02/2009US20090170803 Adjunctive treatment of biological diseases
07/02/2009US20090170724 Labelled nucleotides
07/02/2009US20090170074 System and method for nucleic acid sequencing by polymerase synthesis
07/02/2009US20090169540 Use Of An Antagonist Of Epac For Treating Human Cardiac Hypertrophy
07/02/2009US20090169507 Purine nucleoside analogues for treating flaviviridae including hepatitis c
07/02/2009US20090169504 Compounds and Pharmaceutical compositions for the treatment of Viral infections
07/02/2009CA2710151A1 Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9h-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as a2ar agonists
07/01/2009EP2074133A2 Components and method for enzymatic synthesis of nucleic acids
07/01/2009EP1594882B1 Process for preparing branched ribonucleosides from 1, 2-anhydroribofuranose intermediates
07/01/2009CN101469012A Method for synthesizing 2-amino-6-methoxy-9-(beta-D-aralino)-9H-purine
07/01/2009CN101469011A Method for synthesizing polysubstituted purine nucleoside compounds
07/01/2009CN101469010A Method for synthesizing gemcitabine hydrochloride
07/01/2009CN101469009A Methods and compositions for treating hepatitis c virus
07/01/2009CN101469008A Capecitabine hydroxy derivatives, preparation thereof and use in capecitabine preparation
07/01/2009CN100506838C Method of producing adenosine disodium triphosphate
06/2009
06/30/2009US7553959 comprises cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes for use in labeling nucleic acids or proteins in assay, and as diagnostic aid in genomics/proteomics
06/30/2009US7553958 eliminating time-consuming chromatography and metal cation presence;
06/30/2009US7553839 5h-pyrrolo[3,2-D] pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
06/30/2009US7553830 Compositions for the delivery of negatively charged molecules
06/30/2009US7553826 Cytarabine monophosphate prodrugs
06/30/2009US7553823 C-pyrazole A2A receptor agonists
06/30/2009US7553624 Binding target to photoactive compound then irradiating with xenon arc lamp
06/30/2009US7553615 Glucose dehydrogenases; glycosides; biochemical diagnostics
06/30/2009CA2386221C Compounds for protecting hydroxyls and methods for their use
06/25/2009US20090162292 Substituted 4--piperidine-1-carboxylic acid esters as a2ar agonists
06/25/2009US20090162282 Substituted 4--piperidine-1-carboxylic acid esters as a2ar agonists
06/24/2009EP2071927A2 Compositions and methods for nucleotide sequencing
06/24/2009EP1590360A4 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
06/24/2009CN100503628C Modified fluorinated nucleoside analogues
06/23/2009US7550581 Guanosine derivatives and use thereof
06/23/2009US7550570 4,7-dichlororhodamine dyes labeled polynucleotides
06/23/2009US7550410 plurality of channels having a photoactivatable reagent flowing through interior and a light source to activate the reagent to biosynthesis; solution phase or solid phase synthesis for drug discovery; synthesis of biopolymer, oligonucleotides, peptides and carbohydrates
06/23/2009CA2402991C Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases
06/23/2009CA2398620C Pyrazine derivatives, pharmaceutical compositions containing them, and intermediates therefor
06/18/2009WO2009074253A2 Clofarabine dietherphospholipid derivatives
06/18/2009US20090156547 1-(2,2-Difluoro-2-deoxy-b-D-ribofuranosyl)-4-(2-propyl-1-oxopentyl)amino-pyrimidin-2-one p-toluenesulfonic acid co-crystal; delivery by mouth;bioavailability; nontoxic; side effect reduction; hydrolysis to gemcitabinewith reduction of the formation of deoxydifluorouridine
06/18/2009US20090156545 Substituted Phosphate Esters of Nucleoside Phosphonates
06/18/2009US20090156544 A1 adenosine receptor agonists
06/18/2009US20090155795 having relatively high coupling efficiency that are particularly useful in nucleic acid synthesis; has a redox active moiety comprising a ferrocene derivative; non-nucleotide ferrocene labels; kits
06/18/2009US20090155211 Methods and Compositions for the Treatment of Autoimmune Disorders Using Clofarabine
06/18/2009CA2707593A1 Clofarabine phospholipid derivatives
06/17/2009EP2070938A1 Clofarabine dietherphospholipid derivatives
06/17/2009EP1390378B1 Pharmaceutically active uridine esters
06/16/2009US7547776 Crystalline fludarabine-phosphate with a purity of at least 99.5%; 9- beta -D-arabinofuranosyl-2-fluoroadenine-5'-O-dihydrogenphosphate; cytotoxic
06/16/2009US7547680 Benzimidazole derivatives and medical uses thereof
06/16/2009US7547530 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof
06/16/2009CA2574904C Antiretroviral enantiomeric nucleotide analogs
06/11/2009WO2009071726A1 Method for the preparation of capecitabine and intermediates used in said method
06/11/2009WO2002099058A3 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
06/11/2009WO2001061028A3 Methods and products for peptide based dna sequence identification and analysis
06/11/2009US20090149648 Nucleotide analogs
06/11/2009US20090149416 2' and 3'-Substituted Cyclobutyl Nucleoside Analogs for the Treatment Viral Infections and Abnormal Cellular Proliferation
06/11/2009US20090149415 Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex
06/11/2009US20090149404 Oligonucleotide analogues and methods utilizing the same
06/10/2009EP2066685A2 Novel 2',3'-methylidene acetyl adenosine prodrugs for use as prodrugs for adenosine receptor agonists
06/10/2009EP2066684A2 5'-modified bicyclic nucleic acid analogs
06/10/2009EP1414797B9 Hepatitis c virus polymerase inhibitors with a heterobicylic structure
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 201